Questions remain following first COVID-19 vaccine results

CanSino and Moderna are the first vaccine makers to report data on safety and neutralization, but the extent of protection these products afford remains unclear.
Dublin, Ireland

Search for this author in:

Neutralizing antibodies are the benchmark for testing SARS-CoV-2 vaccines. Brain light / Alamy Stock Photo

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.